Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haitao Pan

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
BMC Medical Research Methodology|December 13, 2021
An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trialsRongji Mu, Zongliang Hu, Guoying Xu, et al.
Journal of Biomedical Materials Research. Part A|March 29, 2014
Effects of functionalization of PLGA-[Asp-PEG]n copolymer surfaces with Arg-Gly-Asp peptides, hydroxyapatite nanoparticles, and BMP-2-derived peptides on cell behavior in vitroHaitao Pan, Qixin Zheng, Shuhua Yang, et al.
Pathology|August 26, 2019
Expanded study on the risk of lymphovascular space invasion and lymph node metastasis of endocervical adenocarcinoma using Pattern Classification: a single-centre analysis of 213 casesHong Xu, Haitao Pan, Yinmei Wang, et al.
BMC Medical Research Methodology|March 28, 2018
Sample size determination for mediation analysis of longitudinal dataHaitao Pan, Suyu Liu, Danmin Miao, et al.
Statistics in Medicine|April 24, 2018
Comparative review of novel model-assisted designs for phase I clinical trialsHeng Zhou, Thomas A Murray, Haitao Pan, et al.
Colloids and Surfaces. B, Biointerfaces|March 1, 2016
Polydopamine-assisted BMP-2-derived peptides immobilization on biomimetic copolymer scaffold for enhanced bone induction in vitro and in vivoHaitao Pan, Qixin Zheng, Xiaodong Guo, et al.
Clinical Trials (London, England)|October 19, 2013
A phase I/II seamless dose escalation/expansion with adaptive randomization scheme (SEARS)Haitao Pan, Fang Xie, Ping Liu, et al.
Contemporary Clinical Trials Communications|October 7, 2022
A software tool for both the maximum tolerated dose and the optimal biological dose finding trials in early phase designsChen Li, Hongying Sun, Cheng Cheng, et al.
Statistics in Medicine|January 29, 2015
Bridging continual reassessment method for phase I clinical trials in different ethnic populationsSuyu Liu, Haitao Pan, Jielai Xia, et al.
Plos One|September 12, 2013
A novel Bayesian seamless phase I/II designHaitao Pan, Ping Huang, Zuoren Wang, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
BMC Medical Research Methodology|December 13, 2021
An adaptive gBOIN design with shrinkage boundaries for phase I dose-finding trialsRongji Mu, Zongliang Hu, Guoying Xu, et al.
Journal of Biomedical Materials Research. Part A|March 29, 2014
Effects of functionalization of PLGA-[Asp-PEG]n copolymer surfaces with Arg-Gly-Asp peptides, hydroxyapatite nanoparticles, and BMP-2-derived peptides on cell behavior in vitroHaitao Pan, Qixin Zheng, Shuhua Yang, et al.
Pathology|August 26, 2019
Expanded study on the risk of lymphovascular space invasion and lymph node metastasis of endocervical adenocarcinoma using Pattern Classification: a single-centre analysis of 213 casesHong Xu, Haitao Pan, Yinmei Wang, et al.
BMC Medical Research Methodology|March 28, 2018
Sample size determination for mediation analysis of longitudinal dataHaitao Pan, Suyu Liu, Danmin Miao, et al.
Statistics in Medicine|April 24, 2018
Comparative review of novel model-assisted designs for phase I clinical trialsHeng Zhou, Thomas A Murray, Haitao Pan, et al.
Colloids and Surfaces. B, Biointerfaces|March 1, 2016
Polydopamine-assisted BMP-2-derived peptides immobilization on biomimetic copolymer scaffold for enhanced bone induction in vitro and in vivoHaitao Pan, Qixin Zheng, Xiaodong Guo, et al.
Clinical Trials (London, England)|October 19, 2013
A phase I/II seamless dose escalation/expansion with adaptive randomization scheme (SEARS)Haitao Pan, Fang Xie, Ping Liu, et al.
Contemporary Clinical Trials Communications|October 7, 2022
A software tool for both the maximum tolerated dose and the optimal biological dose finding trials in early phase designsChen Li, Hongying Sun, Cheng Cheng, et al.
Statistics in Medicine|January 29, 2015
Bridging continual reassessment method for phase I clinical trials in different ethnic populationsSuyu Liu, Haitao Pan, Jielai Xia, et al.
Plos One|September 12, 2013
A novel Bayesian seamless phase I/II designHaitao Pan, Ping Huang, Zuoren Wang, et al.
Pageof 11